Effectiveness of treatment for knee osteoarthritis assessed in Norway

23

Aug 2019

In July 2019, the Norwegian Institute of Public Health (NIPH) has released a report for the effectiveness of treatment for knee osteoarthritis: the evidence base for shared decision making, which aimed to summarize key findings from systematic reviews about relevant treatment options to ease the symptoms in patients with arthritis in the knee.

NIPH came to the following conclusions:

  • NIPH came to the following conclusions:

  • Seven relevant systematic reviews regarding the effectiveness of exercise, self-management education program, physical aids such as braces and orthoses, surgery such as osteotomy and arthroplasty and the use of paracetamol were identified
  • The summary tables were presented with the following primary outcomes provided:
    • Exercise moderately reduces pain
    • Self-management education program may give little or no difference in pain
    • Physical aids such as braces and orthoses probably offer little or no difference in pain
    • It is uncertain if noncompartmental knee arthroplasty is superior to total knee arthroplasty in pain
    • Paracetamol minimally reduces pain

See the full health technology assessment report in English and Norwegian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more